Home

arrow iconNewsarrow iconarrow icon

Low-Carbon Inhalers Approved for COPD Treatment in the India

Low-Carbon Inhalers Approved for COPD Treatment in the India

According to AstraZeneca, the Medicines and Healthcare Products Regulatory Agency(MHRA) has approved a low-carbon version of a triple combination pressurised metred dose (pMDI) inhaler designed for adults with moderate-to-severe chronic obstructive pulmonary disease (COPD).

By BGS

09 Jul 2025

1 min read

Low-Carbon Inhalers

Low-Carbon Inhalers

The propellant hydrofluoroalkane-134a (HFA-134a), which has a high Global Warming Potential (GWP), is currently used in the budesonide/glycopyrronium/formoterol fumarate inhaler (marketed under the Trixeo Aerosphere brand).

With a GWP 99.9% lower than the original propellant, the authorised next-generation propellant hydrofluoroolefin-1234ze (HFO-1234ze(E)) is a fluorinated gas.

By making this modification, the triple combination inhaler’s carbon footprint is on par with that of propellant-free dry powder low-Carbon inhalers.


0 views

Share

BGS

Send Enquiry for this Story

Related Articles

Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem

Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem

Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem Lorem

IUI

1 min read

INDIAN HEALTH idduuw

INDIAN HEALTH idduuw

The aging population poses unique challenges for healthcare systems, requiring adjustments in care delivery. Geriatric care focuses on managing age-related conditions, promoting independence, and improving the quality of life for older adults, ensuring they receive proper support.of life for older adults, ensuring they receive proper support.

IUI

1 min read

A3 Ethicald Collaboration in Healthcare: New Principles Adopted

A3 Ethicald Collaboration in Healthcare: New Principles Adopted

Leading healthcare organizations unite to develop a code of ethics for the use of health data and technology.

IUI

1 min read

A pharmacy benefit manager stopped covering a GLP-1 for obesity. Now there’s a lawsuit.

A pharmacy benefit manager stopped covering a GLP-1 for obesity. Now there’s a lawsuit.

A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to treat obesity.

IUI

1 min read

SMH ROCKZ

SMH ROCKZ

Design for Neurodiversity: driving change for the betterDesign for Neurodiversity: driving change for the betterDesign for Neurodiversity: driving change for the better

IUI

1 min read

NHS Performance Standards Tested as Patients Volume Grows

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure throughout the summer, in spite of it often being a time for them to catch their breath, as per the Health Foundation.

IUI

1 min read

Rethinking Staffing Solutions: The Case for Per Diem Nursing

Rethinking Staffing Solutions: The Case for Per Diem Nursing

While the nursing shortage has improved, it remains a critical issue. With over 1.5 million job openings across the industry—down from 2 million during the pandemic’s height—the demand for nursing professionals is urgent. The pandemic pushed many nurses to leave the profession or switch to less demanding roles. As a result, hospitals increasingly relied on traveling nurses—a temporary fix that has proven financially unsustainable.

IUI

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address